Law firm Bleichmar Fonti & Auld LLP announced on November 3, 2026 that a securities fraud class action lawsuit, captioned Perusek v. The Ensign Group, Inc., et al., No. 8:26-cv-02963, has been filed against The Ensign Group, Inc. (NASDAQ:ENSG) and certain of its senior executives in the U.S. District Court for the Central District of California.

Key Highlights

  • Lead Plaintiff Deadline: Investors have until December 7, 2026 to ask the court to be appointed to lead the case.
  • Largest alleged stock drop: Ensign shares fell $13.88 per share, or 8.15%, on June 8, 2026, from a closing price of $170.30 to $156.42.
  • Second drop: Shares fell $4.52 per share, or 2.98%, on June 11, 2026, from $151.65 to $147.13, following a Muddy Waters Research report.
  • Third drop: Shares fell $2.19 per share, or 1.4%, to close at $153.65 on June 18, 2026, following a Hunterbrook Media follow-up report.
  • Claims asserted: The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
  • Alleged misconduct: The complaint alleges concealment of understaffing, patient neglect, manipulation of quality and staffing data, improper billing, and an administrator-license rental scheme.

Allegations Against The Ensign Group and Three Stock Price Declines

According to the announcement by Bleichmar Fonti & Auld LLP, the class action complaint alleges that Ensign and certain senior executives made materially false and misleading statements about the company's business practices. The complaint alleges that "Defendants concealed systematic understaffing and patient neglect, manipulated reported quality and staffing data, engaged in improper Medicare and Medicaid billing and upcoding, and used licensed administrators who did not actually manage certain facilities." These are allegations contained in the complaint, not established facts.

The filing attributes three separate stock price declines to the publication of third-party investigative reports. On June 8, 2026, Hunterbrook Media published a report titled "Ensign: The Nursing Home Empire Built on Fatal Neglect," which the filing states alleged that Ensign acquired distressed nursing facilities, reduced registered-nurse and skilled-care hours, and used self-reported data to improve quality ratings. On June 11, 2026, Muddy Waters Research published a report alleging that licensed administrators were seldom present at certain facilities, and estimated the alleged practices existed at approximately 20% of Ensign's skilled nursing facilities. On June 18, 2026, Hunterbrook published a follow-up report alleging additional evidence of resident hunger, inadequate supplies, and staffing-data falsification.

The complaint was filed on behalf of investors in Ensign securities and is pending in the U.S. District Court for the Central District of California under case number 8:26-cv-02963. The law firm states that representation is on a contingency fee basis and that shareholders are not responsible for court costs or litigation expenses. The firm has noted it will seek court approval for any potential fees and expenses.

What Was Disclosed

Bleichmar Fonti & Auld LLP announced a securities fraud class action against NASDAQ:ENSG and certain senior executives, citing three stock drops in June 2026 following third-party investigative reports, with a lead plaintiff deadline of December 7, 2026.